Kimberly Fischer, MD
Urology · White Marsh, VANPI 1770744963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in VA, where the typical reported total is $2,551.
Across 41 payments — averaging $28.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$156
- Astellas Pharma US Inc$112
- Procept Biorobotics Corporation$98
- Endo USA, Inc.$94
- Axonics, Inc.$87
- Teleflex LLC$85
- plus $535 from 11 others
What the payments were for
- Food & beverage$1,166100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $156 |
| Astellas Pharma US Inc | 5 | $112 |
| Procept Biorobotics Corporation | 1 | $98 |
| Endo USA, Inc. | 5 | $94 |
| Axonics, Inc. | 1 | $87 |
| Teleflex LLC | 1 | $85 |
| Johnson & Johnson | 3 | $83 |
| Laborie Medical Technologies Corp. | 2 | $76 |
| Boston Scientific | 1 | $66 |
| AbbVie | 3 | $65 |
| Urogen Pharma, Inc. | 3 | $64 |
| Bayer | 2 | $47 |
| Blue Earth Diagnostics | 2 | $43 |
| Immunitybio, Inc. | 2 | $32 |
| Merck | 1 | $27 |
| Pfizer | 1 | $17 |
| Coloplast | 1 | $14 |
How this compares
$1,166 in reported general payments places this provider in the 35th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trospium Chloride ErTrospium Chloride | 27 | $6,194 |
| Tolterodine Tartrate ErTolterodine Tartrate | 22 | $3,516 |
| Tamsulosin Hcl | 109 | $2,127 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 92 | $2,046 |
| Estradiol | 27 | $1,690 |
| Trospium Chloride | 14 | $1,682 |
| Solifenacin Succinate | 26 | $1,464 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 32 | $936 |
| Finasteride | 55 | $601 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $312 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $133 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $132 |
| Ciprofloxacin Hcl | 14 | $103 |
| Levofloxacin | 37 | $47 |
Paid to pharmacies, not to this prescriber.
Other urology in White Marsh
- Michael FabrizioVirginia Beach$1.5M
- Gregg EureVirginia Beach$1.4M
- Jessica DelongVirginia Beach$578K
- Robert GivenVirginia Beach$157K
- Michael WilliamsVirginia Beach$144K
- Nilay GandhiWoodbridge$138K
- Shawn MarhamatiWoodbridge$130K
- Patrick WhelanSuffolk$114K
- Jennifer Miles-ThomasVa Beach$101K
- Charles DanielRoanoke$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.